However, clinicians must remain cautious about side effects, including urinary tract infections, genital mycotic infections, and rare but serious cases of diabetic ketoacidosis
This separation protects both clarity and compliance
Evers said the Pharmacare program in the majority of provinces, including in Atlantic Canada, does not cover the cost of GLP-1 drugs for obesity because it has not yet been recognized as a chronic disease
At DNA Health, we usually recommend Injectable B P C-157 as it is considered the most effective method, especially when targeting specific injuries or tissues (like muscles, ligaments, or tendons)
For small peptides this can help somewhat, but the data is thin